Ind-Swift (INDSWFTLAB) | Stock Overview & Key Data
Ind-Swift Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹296.50 on December 20, 2004
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Mar 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ind-Swift
INDSWFTLAB
|
11.98B Small-cap | 19.04% | 19.20% | 18.12% | 69.63% | 79.14% | 87.37% | 115.45% | 76.77% | 265.65% | 53.11% | 93.40% |
|
Sun Pharmaceutical
SUNPHARMA
|
3.88T Large-cap | -2.77% | -1.84% | 2.13% | -0.53% | 4.00% | 7.25% | 79.99% | 166.96% | 144.01% | 669.48% | 2,278.32% |
|
Divi's Laboratories
DIVISLAB
|
1.69T Large-cap | -3.26% | -1.31% | 2.02% | 1.80% | 2.98% | 0.83% | 89.86% | 56.44% | 484.44% | 1,625.50% | 9,907.51% |
|
Sun Pharma Advanced
SPARC
|
46.75B Small-cap | -13.30% | 46.20% | 62.20% | 26.84% | 51.26% | 14.56% | 13.10% | -5.14% | -23.02% | 148.11% | -27.03% |
|
Innova Captab
INNOVACAP
|
41.43B Small-cap | 2.24% | 2.13% | 29.82% | 21.15% | 16.79% | -3.19% | 57.07% | 57.07% | 57.07% | 57.07% | 57.07% |
|
Gujarat Themis
GUJTHEM
|
35.41B Small-cap | 7.42% | 6.10% | 33.40% | -1.19% | -10.34% | 31.69% | 84.69% | 84.69% | 84.69% | 84.69% | 84.69% |
Ownership & Short Interest
Calculate Your Ind-Swift Investment Returns
Long-Term Investment Performance Analysis
Ind-Swift stock price in May 2016 was ₹41.60, A ₹1,000.00 lump sum investment in Ind-Swift made 10 years ago would be worth approximately ₹3,776.68 today, representing a outstanding return of 277.67%. This translates to an annualized return (CAGR) of 14.20%.
10 Years Investment Scenario (May 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is INDSWFTLAB's 52-week high and low?
- In the last 52 weeks, Ind-Swift reached a high of ₹173.25 (on June 1, 2026) and a low of ₹81.90 (on June 3, 2025).
- What is the market cap and P/E ratio for INDSWFTLAB?
- Curious about Ind-Swift's size and valuation? Its market capitalization stands at 11.98B. When it comes to valuation, the P/E ratio (trailing twelve months) is 4.00, and the forward P/E (looking ahead) is N/A.
- Does INDSWFTLAB pay dividends? If so, what's the yield?
- As for dividends, Ind-Swift isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Ind-Swift's main competitors or similar companies to consider before investing?
When looking at Ind-Swift, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.88T Healthcare Drug Manufacturers - Specialty & Generic 7.25% 79.99% Divi's Laboratories
DIVISLAB1.69T Healthcare Drug Manufacturers - Specialty & Generic 0.83% 89.86% Sun Pharma Advanced
SPARC46.75B Healthcare Drug Manufacturers - Specialty & Generic 14.56% 13.10% Innova Captab
INNOVACAP41.43B Healthcare Drug Manufacturers - Specialty & Generic -3.19% 57.07% Gujarat Themis
GUJTHEM35.41B Healthcare Drug Manufacturers - Specialty & Generic 31.69% 84.69% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Ind-Swift Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Ind-Swift's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 21.35%, the Debt to Equity ratio from the most recent quarter is 1.69, and its Gross Profit Margin stands at 53.44%.
- What is the recent revenue and earnings growth for INDSWFTLAB?
- Looking at Ind-Swift's growth, its revenue over the trailing twelve months (TTM) was INR6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 1,641.10%, and quarterly earnings saw a YoY growth of 153,743.50%.
- How much of INDSWFTLAB stock is held by insiders and institutions?
- Wondering who owns Ind-Swift stock? Company insiders (like executives and directors) hold about 66.37% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 4.62%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.